AU2003259713A1 - Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same - Google Patents

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Info

Publication number
AU2003259713A1
AU2003259713A1 AU2003259713A AU2003259713A AU2003259713A1 AU 2003259713 A1 AU2003259713 A1 AU 2003259713A1 AU 2003259713 A AU2003259713 A AU 2003259713A AU 2003259713 A AU2003259713 A AU 2003259713A AU 2003259713 A1 AU2003259713 A1 AU 2003259713A1
Authority
AU
Australia
Prior art keywords
same
hyperproliferative
identifying
detecting
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259713A
Other languages
English (en)
Other versions
AU2003259713A8 (en
Inventor
Roger Briesewitz
John H Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of AU2003259713A8 publication Critical patent/AU2003259713A8/xx
Publication of AU2003259713A1 publication Critical patent/AU2003259713A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003259713A 2002-08-09 2003-08-08 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same Abandoned AU2003259713A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40233002P 2002-08-09 2002-08-09
US60/402,330 2002-08-09
US44049103P 2003-01-16 2003-01-16
US60/440,491 2003-01-16
PCT/US2003/024992 WO2004015082A2 (en) 2002-08-09 2003-08-08 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Publications (2)

Publication Number Publication Date
AU2003259713A8 AU2003259713A8 (en) 2004-02-25
AU2003259713A1 true AU2003259713A1 (en) 2004-02-25

Family

ID=31720590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259713A Abandoned AU2003259713A1 (en) 2002-08-09 2003-08-08 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Country Status (5)

Country Link
US (4) US7195876B2 (enExample)
EP (1) EP1576129A4 (enExample)
JP (2) JP4588447B2 (enExample)
AU (1) AU2003259713A1 (enExample)
WO (1) WO2004015082A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0500111A3 (en) * 2001-12-27 2009-10-28 Theravance Indolinone derivatives useful as protein kinase inhibitors
WO2003105773A2 (en) 2002-06-01 2003-12-24 Oregon Health & Science University Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:
US7195876B2 (en) * 2002-08-09 2007-03-27 Theravance, Inc. Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
DE602004022540D1 (de) 2003-05-27 2009-09-24 Robert P Haegerkvist Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes
EP1699477A2 (en) * 2003-12-11 2006-09-13 Theravance, Inc. Compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases
EP1991531A1 (en) * 2006-02-28 2008-11-19 Amgen Inc. Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69011329T2 (de) 1989-05-22 1994-12-08 Zymogenetics, Inc., Seattle, Wash. Pdgf-alpha-rezeptor.
US5521184A (en) 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
CO4950519A1 (es) 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
WO2000078952A2 (en) 1999-06-17 2000-12-28 Incyte Genomics, Inc. Human rna metabolism proteins (rmep)
ATE369359T1 (de) 2000-02-15 2007-08-15 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
ATE402169T1 (de) 2000-08-18 2008-08-15 Millennium Pharm Inc Quinazolin-derivate als kinase inhibitoren
HUP0500111A3 (en) 2001-12-27 2009-10-28 Theravance Indolinone derivatives useful as protein kinase inhibitors
US7195876B2 (en) * 2002-08-09 2007-03-27 Theravance, Inc. Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Also Published As

Publication number Publication date
US7195876B2 (en) 2007-03-27
JP2006515983A (ja) 2006-06-15
EP1576129A4 (en) 2008-01-23
JP4588447B2 (ja) 2010-12-01
JP2010279376A (ja) 2010-12-16
WO2004015082A2 (en) 2004-02-19
AU2003259713A8 (en) 2004-02-25
US20100112661A1 (en) 2010-05-06
WO2004015082A3 (en) 2007-04-26
US7604944B2 (en) 2009-10-20
US20090087881A1 (en) 2009-04-02
EP1576129A2 (en) 2005-09-21
US20040045044A1 (en) 2004-03-04
US20080102472A1 (en) 2008-05-01
US7585653B2 (en) 2009-09-08

Similar Documents

Publication Publication Date Title
WO2003083054A9 (en) Amylases, nucleic acids encoding them and methods for making and using them
WO2004033668A8 (en) Proteases, nucleic acids encoding them and methods for making and using them
ZA200500171B (en) Xylanases, nucleic acids encoding them and methods for making and using them
IL166751A0 (en) Modified transferin-antibody fusion proteins
WO2002101078A8 (en) Cellulases, nucleic acids encoding them and methods for making and using them
EP1497418A4 (en) PHOSPHOLIPASES, NUCLEIC ACIDS ENCODING THESE PHOSPHALIPASES AND METHODS OF MAKING AND USING
EP1441227A3 (en) Functional beads, method for reading the same and bead-reading apparatus
IL169820A0 (en) Amino acids with affinity for the alpha-2-delta-protein
AU2003285906A1 (en) Amylases, nucleic acids encoding them and methods for making and using them
AU2003220322A1 (en) Methods for identifying polypeptide factors interacting with rna
AU2003252111A1 (en) Fluorescent proteins, nucleic acids encoding them and methods for making and using them
AU2003278072A1 (en) Functionalised ionic liquids and method for the production thereof
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
AP2006003544A0 (en) Amino acids with affinity for the alpha2delta-protein.
AU2003259713A1 (en) Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
AU2003234274A1 (en) D1-1 nucleic acids, polypeptides and related methods
EP1585760A4 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES BTL-II
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2003264075A1 (en) Active fusion proteins and method for the production thereof
AU2003218225A1 (en) Posh nucleic acids, polypeptides and related methods
AU2003230516A1 (en) Fusion polypeptide, use thereof and methods employing it
AU2002352508A1 (en) Fusion proteins, method for the production and use thereof
AU2003223861A1 (en) Optical element, method for the production thereof and for determining its optical properties
AU2003214893A1 (en) Method for detecting remote homologues and novel kinases identified with the method
AU2003235099A1 (en) Novel proteins and dnas encoding the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase